Stock MYCO MYDECINE INNOVATIONS GROUP INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Mydecine Innovations Group Inc. NEO Exchange

Equities

MYCO

CA62849F2008

End-of-day quote NEO Exchange
Other stock markets
 03:30:00 06/10/2023 am IST 		5-day change 1st Jan Change
0.175 CAD +45.83% Intraday chart for Mydecine Innovations Group Inc. +29.63% -61.11%
05/07 Mydecine Innovations Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02/07 Mydecine Innovations Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Mydecine Announces Filing of Audited and Q1 Financial Statements
AQ
Mydecine Innovations Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Mydecine Innovations Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Mydecine Provides Bi-Weekly Status Report
AQ
Mydecine Provides Bl-Weekly Status Report
AQ
Mydecine Applies for Management Cease Trade Order
AQ
Mydecine Receives Management Cease Trade Order
AQ
Mydecine Innovations Group Inc. Announces Restructuring Transactions and Annual General and Special Meeting
AQ
Mydecine Innovations Group Inc. announced that it expects to receive CAD 1 million in funding
CI
Mydecine Announces Intention to Refile Certain Financial Statements and Applies for Management Cease Trade Order
AQ
Mydecine Innovations Group Inc. Announces Share for Debt Settlement
AQ
Mydecine Innovations Closes Partial Debt Settlement
MT
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
GL
Mydecine Innovations Group Receives Two Notice of Allowances from USPTO for its MYCO-005 and MYCO-006 Family of Compounds
AQ
Mydecine Innovations Group Announces Director Resignation
GL
Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director
CI
Mydecine Innovations Group Receives Notice of Allowance from USPTO For MYCO-005 Compound
MT
Mydecine Innovations Group Receives Notice of Allowance from USPTO for its MYCO-005 Compound
GL
Mydecine Announces Update Regarding the Special Access Program
GL
Mydecine Innovations Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MYCOF Stock
  4. MYCO Stock
  5. News Mydecine Innovations Group Inc.